HLBPHARMA

The current price of 047920 is 31650 KRW — it has increased by 0.64% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HLBPHARMA stocks are traded under the ticker 047920.

047920 stock is 6.51% volatile and has beta coefficient of 2.11. Check out the list of the most volatile stocks — is HLBPHARMA there?

Yes, you can track HLBPHARMA financials in yearly and quarterly reports right on TradingView.

047920 stock has risen by 4.80% compared to the previous week, the month change is a 2.31% fall, over the last year HLBPHARMA has showed a 115.01% increase.

047920 net income for the last quarter is ‪5.19 B‬ KRW, while the quarter before that showed ‪−7.64 B‬ KRW of net income which accounts for 167.90% change. Track more HLBPHARMA financial stats to get the full picture.

No, 047920 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 047920 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HLBPHARMA stock right from TradingView charts — choose your broker and connect to your account.

047920 reached its all-time high on Mar 21, 2024 with the price of 42050 KRW, and its all-time low was 2650 KRW and was reached on Mar 23, 2020.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 222.00 employees. See our rating of the largest employees — is HLBPHARMA on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HLBPHARMA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HLBPHARMA stock shows the buy signal. See more of HLBPHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HLBPHARMA EBITDA is ‪−14.98 B‬ KRW, and current EBITDA margin is −11.24%. See more stats in HLBPHARMA financial statements.